Don't let the pundit-speak about "lagging indicator" or the market's move Friday fool you, the job market is crucial to the stock market right now.     Read More

Companies including TD Ameritrade, Coach and Turkey's Turkcell could be on Warren Buffett's radar, according to a quantitative screen by Standard & Poor's.   Read More

Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!   Read More

Shares of the French drugmaker are getting pummeled over at least three analyst reports identifying a leak about a study or studies that could go public soon. Their research suggests the data is related to a suspected or "theoretical" higher cancer risk associated with SNY's Lantus.    Read More

For people struggling with diabetes, the bathroom scale can be the enemy. But new developments may change that and more!   Read More

In less than two weeks, there've been four pretty significant events in biopharma. And, hopefully, after ADA things will begin to settle down a bit for the summer.    Read More

It's going to be a crazy busy, stressful couple of weeks. A shareholder meeting, a medical meeting, then another shareholder meeting and finally another medical meeting.    Read More

Fiesta time started a little earlier than expected for investors in Eli Lilly, Amylin Pharmaceuticals and Alkermes. The companies had said they would file for Food and Drug Administration approval of the once-a-week version of the diabetes drug Byetta in the second quarter, but most analysts thought that meant June.    Read More